Buprenorphine And Naloxone Tablet
Product Images NDC 0121-1018

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0121-1018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride)

Chemical structure of buprenorphine hydrochloride depicted with labeled molecular bonds and groups including hydroxyl, methoxy, and a cyclopropylmethyl group.*

FDA Label Image

Chemical Structure (Naloxone Hydrochloride Dihydrate)

Chemical structure of buprenorphine hydrochloride dihydrate. The diagram shows the molecular arrangement including functional groups and the HCl and 2H2O components indicating the hydrochloride salt and hydration.*

FDA Label Image

Figure 3 (Buprenorphine Naloxone 03)

An instructional illustration showing a person placing a tablet under the tongue, indicating sublingual administration. The diagram highlights the mouth open wide with a single tablet being positioned on the lower gum beneath the tongue.*

FDA Label Image

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label (Buprenorphine Naloxone 04)

Label for Buprenorphine and Naloxone Sublingual Tablets 2 mg / 0.5 mg, with 30 tablets in the package. The label shows the active ingredients as buprenorphine hydrochloride 2.16 mg and naloxone hydrochloride 0.61 mg per tablet. It includes storage instructions, manufacturer information (Ethypharm S.A. in France), distributor PAI Pharma in Greenville, SC, and a barcode. The label states 'Rx only' and includes a control number and a reference to a medication guide for pharmacists to dispense.*

FDA Label Image

8 mg/2 mg Sublingual Tablet 30-count Bottle Label (Buprenorphine Naloxone 05)

Label for Buprenorphine and Naloxone Sublingual Tablets, 8 mg / 2 mg, containing 30 tablets. The label shows the product is Rx only and includes instructions for pharmacists to dispense the medication guide. Manufacturer information lists Ethypharm S.A. in France and PAI Pharma in Greenville, SC. Storage instructions and a tamper-evident cap opening note are present, along with a barcode and NDC 0121-2036-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.